Efectos de las intervenciones del farmacéutico en pacientes polimedicados

Abstract

Polypharmacy, the state of being prescribed or taking more medications than clinically appropriate, can result in a variety of negative outcomes for both patients and healthcare facilities. These include negative outcomes such as adverse drug effects, hospitalizations, and poor patient health, as well as economic outcomes such as increased drug cost and costs associated with increased utilization of health services. Available data suggests pharmacists have the potential to have a large effect in combating this problem through a variety of interventions such as reducing the number of medications taken, reducing the number of doses taken, increasing patient adherence, preventing adverse drug reactions (ADRs), improving patient quality of life and decreasing facility and drug costs. A small number of studies have been performed on the pharmacists' role in addressing the problem of polypharmacy; however, they include various populations, settings, and measured outcomes. Furthermore, some of the results are conflicting. Nonetheless, this review of the available literature concludes that pharmacist interventions can improve patient outcomes. With the ever-increasing costs of healthcare, the substantial cost savings for patients as well as institutions provided by these interventions are further justification for widespread implementation of pharmacist interventions at healthcare institutions.

Pharmacist care activities: a bibliometric analysis

“…Such characteristics lead these patients to require continuous follow-up in order to guarantee the effectiveness and safety of their pharmacological treatment. [32][33][34][35] The results of this bibliometric analysis emphasise the need for further studies in the paediatric population, which may be considered a priority because of the inherent risks of the use of medicines in children given their particular physiological characteristics. [36][37][38] The number of original papers included in each SR/ MA was highly variable.…”

“…The predominance of SR/MAs on adult and elderly patients can be explained by the higher incidence of chronic diseases in these age groups, which results in a greater frequency of medication use, and with ageing comes a higher frequency of polymedication. Such characteristics lead these patients to require continuous follow‐up in order to guarantee the effectiveness and safety of their pharmacological treatment . The results of this bibliometric analysis emphasise the need for further studies in the paediatric population, which may be considered a priority because of the inherent risks of the use of medicines in children given their particular physiological characteristics …”

Prevalence of Polypharmacy in Patients With Vestibular and Balance Complaints

“…Deprescribing is the process by which medications in a patient’s profile are reviewed and stopped if deemed to be clinically inappropriate or the cause of adverse effects (Molokhia & Majeed 2017). It has multiple benefits, including reduction of medication burden, cost, adverse effects, and potential drug-drug interactions (Chumney & Robinson 2006). Although no standardized set of guidelines for deprescribing exist, there are several evidence-based methods proposed by various organizations (Barnett et al 2016; Halli-Tierney et al 2019; Molokhia & Majeed 2017; O’Mahony et al 2014).…”

Seguimiento del paciente anciano polimedicado en un área de salud

“…En la evaluacio ´n farmacoterape ´utica de pacientes polimedicados la intervencio ´n farmace ´utica puede adoptar distintas estrategias 19 , una de las ma ´s eficientes parece ser la revisio ´n por parte del farmace ´utico del plan terape ´utico del paciente, elaboracio ´n de un IFT y discusio ´n posterior con el me ´dico responsable 20 . La rapidez de elaboracio ´n de los informes y la comunicacio ´n a ´gil con el me ´dico de familia es un factor determinante, ya que se debe garantizar que la informacio ´n relacionada con la medicacio ´n que toma el paciente y que se refleja en el IFT este ´lo ma ´s actualizada posible.…”